product summary
Loading...
company name :
R&D Systems
product type :
antibody
product name :
PPIL2 Antibody (010) [DyLight 680]
catalog :
NBP2-90281FR
quantity :
0.1 ml
price :
539 USD
clonality :
monoclonal
host :
domestic rabbit
conjugate :
DyLight680
clone name :
010
reactivity :
human
application :
ELISA
more info or order :
product information
brand :
Novus
master code :
NBP2-90281FR
SKU :
NBP2-90281FR
product name :
PPIL2 Antibody (010) [DyLight 680]
sizes available :
0.1 ml
description :
The PPIL2 Antibody (010) [DyLight 680] from NBP2-90281FR is a 6.7e-05 antibody to . This antibody reacts with human.
target :
PPIL2
category :
Primary Antibodies
buffer :
50mM Sodium Borate
clonality :
Monoclonal
clone :
010
conjugate :
DyLight 680
all_available conjugate :
DyLight 680
dilution :
ELISA
host :
Rabbit
immunogen :
This antibody was obtained from a rabbit immunized with purified, recombinant Human PPIL2 (Uniprot#: Q13356-2; Gly280-Pro457).
isotype :
IgG
purity :
Protein A purified
species :
Human
gene symbol :
PPIL2
applications :
ELISA
extended description :
Recombinant Monoclonal Antibody
USD :
539 USD
product details :
Recombinant Monoclonal Antibody
alt names :
CYC4, cyclophilin, 60kDa, cyclophilin-60, Cyclophilin-like protein Cyp-60, Cyp-60, CYP60, EC 5.2.1.8, FLJ39930, hCyP-60, MGC33174, MGC787, peptidylprolyl cis-trans isomerase, peptidyl-prolyl cis-trans isomerase-like 2, peptidylprolyl isomerase (cyclophilin)-like 2, PPIase, Rotamase PPIL2
storage :
Store at 4C in the dark.
more info or order :
company information

R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.
related products
browse more products
questions and comments
